Cita APA

Brandberg, Y., Johansson, H., Hellström, M., Gnant, M., Möbus, V., Greil, R., . . . Bergh, J. (2020). Long-term (up to 16 months) health-related quality of life after adjuvant tailored dose-dense chemotherapy vs. standard three-weekly chemotherapy in women with high-risk early breast cancer. Breast Cancer Res Treat.

Chicago Style Citation

Brandberg, Yvonne, Hemming Johansson, Mats Hellström, Michael Gnant, Volker Möbus, Richard Greil, Theodoros Foukakis, i Jonas Bergh. "Long-term (up to 16 months) Health-related Quality of Life After Adjuvant Tailored Dose-dense Chemotherapy Vs. Standard Three-weekly Chemotherapy in Women With High-risk Early Breast Cancer." Breast Cancer Res Treat 2020.

Cita MLA

Brandberg, Yvonne, et al. "Long-term (up to 16 months) Health-related Quality of Life After Adjuvant Tailored Dose-dense Chemotherapy Vs. Standard Three-weekly Chemotherapy in Women With High-risk Early Breast Cancer." Breast Cancer Res Treat 2020.